SARS-CoV-2 coinfections among pertussis cases identified through the Enhanced Pertussis Surveillance system in the United States, January 2020–February 2023
Although the prevalence of pertussis patients with SARS-CoV-2 coinfections was low, patients with coinfections reported more severe complications and outcomes compared to those with pertussis alone. Given the decline in reported pertussis cases during the COVID-19 pandemic, continued monitoring of pertussis incidence alongside respiratory viral infections will be important as the pertussis burden returns to pre-pandemic levels.
Authors
- Adam Misiorski
- Erin Youngkin
- Isha Berry (ORCID: https://orcid.org/0000-0003-3138-664X)
- Emma Stanislawski (ORCID: https://orcid.org/0000-0002-0341-9494)
- Tami H. Skoff
- Fiona P. Havers (ORCID: https://orcid.org/0000-0001-9873-6195)
- Benjamin J. Silk
- Amy B Rubis
- Matthew Cole (ORCID: https://orcid.org/0000-0002-9205-9055)
- Samantha Sefton (ORCID: https://orcid.org/0000-0001-9491-0301)
- Suzanne McGuire
- Noel Silhan
- Yeng Vang
Institutions
- Centers for Disease Control and Prevention (US)
- New Mexico Department of Health (US)
- New York State Department of Health (US)
- Colorado Department of Public Health and Environment (US)
- Oregon Health Authority (US)
- Emory University (US)
- National Center for Immunization and Respiratory Diseases (US)
- Epidemic Intelligence Service (US)
- Connecticut Department of Public Health (US)
- Minnesota Department of Health (US)
- Atlanta VA Medical Center (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1371/journal.pone.0311488
- Citations
- 3
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Centers for Disease Control and Prevention